InvestorsHub Logo
Followers 5
Posts 127
Boards Moderated 0
Alias Born 11/15/2015

Re: georgejjl post# 323930

Tuesday, 08/03/2021 4:34:05 PM

Tuesday, August 03, 2021 4:34:05 PM

Post# of 462745


If we thought we needed 3 trials for approval…think again. We may be closer than we think! https://www.raps.org/news-and-articles/news-articles/2019/5/almost-half-of-all-new-drug-approvals-in-2018-reli on the Anavex board and include this quote from the article-

"Most recently, IQVIA released a report finding that 25 of 59 (42%) novel drugs approved in 2018 were approved on the basis of only one trial. And one out of eight approvals relied only on Phase 1 or 2 trials, with no Phase 3 trials. But as in previous years, a large portion of the drugs relying on only one trial were new orphan and cancer drugs."

Promising for Rett and maybe AD as well given Phase 2b/3 trial designation and that there is nothing worthwhile approved for AD ... and it will kill you in time

Hang in there everybody
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News